Publisher Correction: Targeting co-stimulatory molecules in autoimmune disease

Nat Rev Drug Discov. 2021 Jan;20(1):82. doi: 10.1038/s41573-020-00116-x.

¹ Institute of Immunity & Transplantation, Division of Infection & Immunity, University College London, Royal Free Campus, London, UK.
² Early Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.
³ Autoimmunity, Transplantation and Inflammation Disease Area, Novartis Institutes for Biomedical Research, Basel, Switzerland.
⁴ Institute of Immunity & Transplantation, Division of Infection & Immunity, University College London, Royal Free Campus, London, UK. [email protected].

No abstract available

Publication types